Archive | Health Professionals

Ideaya Biosciences Begins Trial of IDE196, Xalkori in Uveal Melanoma Patients

San Francisco-based Ideaya Biosciences on Tuesday said that it has dosed its first uveal melanoma patient in a clinical trial evaluating its PKC inhibitor IDE196 with Pfizer’s cMET inhibitor crizotinib (Xalkori).

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

Texas A&M Research Explores How Melanoma Grows And Spreads

The first step in treating cancer is understanding how it starts, grows and spreads throughout the body.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Ultraviolet radiation causes rare type of eye cancer

Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma, according to University of Manchester research funded by Cancer Research UK and others* and published** in Nature Communications today (Monday).

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Advanced humanized mouse model helps better understand immunotherapy resistance in melanoma

Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance to immune checkpoint blockade therapies in melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest